T Symonds

Summary

Affiliation: Pfizer Global Research and Development
Country: USA

Publications

  1. ncbi The ability of the general male public to assess their suitability to take 50-mg sildenafil: an assessment of the comprehension of patient information materials via internet survey
    Tara Symonds
    Pfizer Ltd, Sandwich, Kent, UK United BioSource Corporation, Bethesda, MD, USA
    J Sex Med 8:2038-47. 2011
  2. ncbi A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment
    Tara Symonds
    Pfizer Inc, New York, NY, USA
    J Sex Med 8:1463-71. 2011
  3. ncbi Further evidence of the reliability and validity of the premature ejaculation diagnostic tool
    T Symonds
    Pfizer Ltd, Sandwich, Kent, UK
    Int J Impot Res 19:521-5. 2007
  4. ncbi Development and validation of a premature ejaculation diagnostic tool
    Tara Symonds
    Pfizer Ltd, Sandwich, Kent, UK
    Eur Urol 52:565-73. 2007
  5. ncbi Development of a questionnaire on sexual quality of life in women
    Tara Symonds
    Pfizer Global Research and Development, Sandwich, United Kingdom
    J Sex Marital Ther 31:385-97. 2005
  6. ncbi Sexual dysfunction in partners of men with premature ejaculation
    K Hobbs
    Worldwide Outcomes Research, Pfizer Ltd, Sandwich, UK
    Int J Impot Res 20:512-7. 2008
  7. ncbi How does premature ejaculation impact a man s life?
    T Symonds
    Pfizer Global Research Development, Sandwich Laboratories, Pfizer Ltd, Kent, United Kingdom
    J Sex Marital Ther 29:361-70. 2003
  8. ncbi A review of condition-specific instruments to assess the impact of urinary incontinence on health-related quality of life
    Tara Symonds
    Outcomes Research, Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent CT13 9NJ, UK
    Eur Urol 43:219-25. 2003
  9. ncbi Psychometric validation of gender nonspecific sexual confidence and sexual relationship scales in men and women
    Lucy Abraham
    Global Outcomes Research, Pfizer Ltd, Sandwich, Kent, UK
    J Sex Med 6:2244-54. 2009
  10. ncbi Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction
    Lucy Abraham
    Global Outcomes Research, Pfizer Ltd, Sandwich, UK
    J Sex Med 5:595-601. 2008

Detail Information

Publications26

  1. ncbi The ability of the general male public to assess their suitability to take 50-mg sildenafil: an assessment of the comprehension of patient information materials via internet survey
    Tara Symonds
    Pfizer Ltd, Sandwich, Kent, UK United BioSource Corporation, Bethesda, MD, USA
    J Sex Med 8:2038-47. 2011
    ..Phosphodiesterase type 5 inhibitors, including sildenafil, are the first-line treatment option for ED. Providing appropriate information regarding suitability for using sildenafil is important...
  2. ncbi A feasibility study comparing pharmacist and physician recommendations for sildenafil treatment
    Tara Symonds
    Pfizer Inc, New York, NY, USA
    J Sex Med 8:1463-71. 2011
    ..In Europe, pharmacists may be an important first point of contact for men with erectile dysfunction (ED) asking for advice and treatment...
  3. ncbi Further evidence of the reliability and validity of the premature ejaculation diagnostic tool
    T Symonds
    Pfizer Ltd, Sandwich, Kent, UK
    Int J Impot Res 19:521-5. 2007
    ..88. In summary, the PEDT is extensively validated, self-report measure that can systematically assess DSM-IV-TR criteria to provide accurate diagnoses of PE/no-PE...
  4. ncbi Development and validation of a premature ejaculation diagnostic tool
    Tara Symonds
    Pfizer Ltd, Sandwich, Kent, UK
    Eur Urol 52:565-73. 2007
    ..Therefore, the aim was to develop a brief, multidimensional, psychometrically validated instrument for diagnosing PE status...
  5. ncbi Development of a questionnaire on sexual quality of life in women
    Tara Symonds
    Pfizer Global Research and Development, Sandwich, United Kingdom
    J Sex Marital Ther 31:385-97. 2005
    ..The SQOL-F is a valid instrument for assessing the impact of FSD on quality of life and as an adjunct in evaluating FSD in clinical trials. The SQOL-F sensitivity to changes in sexual function needs confirmation...
  6. ncbi Sexual dysfunction in partners of men with premature ejaculation
    K Hobbs
    Worldwide Outcomes Research, Pfizer Ltd, Sandwich, UK
    Int J Impot Res 20:512-7. 2008
    ..7% of PE partners had at least one sexual dysfunction, compared to 42.7% of the control group. Further research needs to be undertaken to investigate the temporal relationship between sexual dysfunctions in both partners...
  7. ncbi How does premature ejaculation impact a man s life?
    T Symonds
    Pfizer Global Research Development, Sandwich Laboratories, Pfizer Ltd, Kent, United Kingdom
    J Sex Marital Ther 29:361-70. 2003
    ..Further investigation will need to determine how prevalent these concerns are in the PE population and also to delineate the impact on the men s partners...
  8. ncbi A review of condition-specific instruments to assess the impact of urinary incontinence on health-related quality of life
    Tara Symonds
    Outcomes Research, Pfizer Global Research and Development, Sandwich Laboratories, Sandwich, Kent CT13 9NJ, UK
    Eur Urol 43:219-25. 2003
    ..Ten instruments were identified: general use (five); urinary urge (OAB) incontinence (four); and stress incontinence (one). Several were identified as valid instruments for assessing HRQoL in urinary incontinence patients...
  9. ncbi Psychometric validation of gender nonspecific sexual confidence and sexual relationship scales in men and women
    Lucy Abraham
    Global Outcomes Research, Pfizer Ltd, Sandwich, Kent, UK
    J Sex Med 6:2244-54. 2009
    ..The SCS assesses how confident an individual feels as a sexual partner, while the SRS assesses feelings that an individual has about their sexual relationship with their partner...
  10. ncbi Psychometric validation of a sexual quality of life questionnaire for use in men with premature ejaculation or erectile dysfunction
    Lucy Abraham
    Global Outcomes Research, Pfizer Ltd, Sandwich, UK
    J Sex Med 5:595-601. 2008
    ..An instrument that can systematically capture the impact of sexual dysfunction on quality of life (QoL) in men is needed...
  11. ncbi Methods to determine the minimum important difference for a sexual event diary used by postmenopausal women with hypoactive sexual desire disorder
    Tara Symonds
    Pfizer Ltd, Kent, UK
    J Sex Med 4:1328-35. 2007
    ..There are issues with calculating an MID using each method: Will the two approaches give the same estimate? If the estimates differ, how do you decide on one estimate? Would asking patients directly be more beneficial?..
  12. ncbi Measuring the impact of venous leg ulcers on quality of life
    A Hareendran
    Worldwide Outcomes Research, Pfizer, Sandwich, UK
    J Wound Care 14:53-7. 2005
    ..To identify health-related quality-of-life (HRQoL) issues in patients with venous leg ulcers, with the aim of generating items for a treatment outcome measure...
  13. ncbi Assessing patients' descriptions of lower urinary tract symptoms (LUTS) and perspectives on treatment outcomes: results of qualitative research
    K S Coyne
    United BioSource Corporation, Bethesda, MD 20814, USA
    Int J Clin Pract 64:1260-78. 2010
    ..Understanding the patient's experience and symptom descriptions is critical to assess outcomes. Thus, there is a need for qualitative research to better understand how patients describe their symptoms and treatment expectations...
  14. ncbi The clinical significance of quality-of-life results: practical considerations for specific audiences
    Tara Symonds
    Outcomes Research Department, Pfizer Ltd, Sandwich, Kent, United Kingdom
    Mayo Clin Proc 77:572-83. 2002
    ..Collectively, this series attempts to provide methods and means for making such determinations...
  15. ncbi Development and validation of a new questionnaire to assess sexual satisfaction, control, and distress associated with premature ejaculation
    Stanley Althof
    Sex and Marital Therapy South Florida, West Palm Beach, FL, USA
    J Sex Med 3:465-75. 2006
    ..This tool has the potential to add value to interpretations of improvements in ejaculation latency resulting from new treatments of PE...
  16. ncbi Outcome measurement in female sexual dysfunction clinical trials: review and recommendations
    Stanley E Althof
    Department of Urology, Case Western Reserve University School of Medicine, USA
    J Sex Marital Ther 31:153-66. 2005
    ..g., sexual desire). Successful and satisfactory encounters represent an amalgam of subjective assessments that are too far removed from the essential FSD component...
  17. ncbi A methodology study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women
    Wulf H Utian
    Department of Reproductive Biology, Case University, Cleveland, Ohio, USA
    J Sex Marital Ther 31:271-83. 2005
    ..The results showed that the method had good convergent validity and excellent intrarater reliability. Thus, we conclude that the SDM can reliably diagnose FSD status and FSD subtypes in postmenopausal women...
  18. ncbi Evaluating the sexual experience in men: validation of the sexual experience questionnaire
    John P Mulhall
    Department of Urology, Weill Medical College of Cornell University, New York, NY, USA
    J Sex Med 5:365-76. 2008
    ..The absence of a single brief measure that assesses function and health-related quality of life (HRQoL) hinders evaluation of the sexual experience in men with erectile dysfunction (ED)...
  19. ncbi Patient reported outcomes used in the assessment of premature ejaculation
    Stanley E Althof
    Case Western Reserve University School of Medicine, Cleveland, OH, USA
    Urol Clin North Am 34:581-9, vii. 2007
    ..The authors hope this helps clinicians and researchers to identify brief, reliable, and valid measures that document treatment effects or identify men with PE...
  20. ncbi Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire
    Lori D McLeod
    RTI Health Solutions, Research Triangle Institute, North Carolina 27709 2194, USA
    Pharmacoeconomics 21:1069-79. 2003
    ..However, the question remained if these statistically significant results were also clinically meaningful...
  21. ncbi Estimation of a preference-based index from a condition-specific measure: the King's Health Questionnaire
    John Brazier
    Section of Health Economics and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK
    Med Decis Making 28:113-26. 2008
    ..Generic preference-based measures of health may not adequately cover the impact of some conditions. There is therefore increasing interest in developing condition-specific preference-based measures...
  22. ncbi Development and validation of the quality of erection questionnaire
    Hartmut Porst
    Private Practice of Urology Andrology, Hamburg, Germany
    J Sex Med 4:372-81. 2007
    ..There are no psychometrically validated assessment tools designed to solely and specifically evaluate satisfaction with the quality of erections...
  23. ncbi A methodology study to develop and validate a screener for hypoactive sexual desire disorder in postmenopausal women
    Sandra Leiblum
    Center for Sexual and Relationship Health, Department of Psychiatry UMDNJ Robert Wood Johnson Medical School, Piscataway, NJ 08854, USA
    J Sex Med 3:455-64. 2006
    ..A previous study reported validity and reliability of a structured diagnostic method created for clinical trials that can be performed in approximately 1 hour...
  24. ncbi Estimating clinically significant differences in quality of life outcomes
    Kathleen W Wyrwich
    Saint Louis University, St Louis, MO 63103, USA
    Qual Life Res 14:285-95. 2005
    ..The original six articles were presented at the Symposium on Clinical Significance of Quality of Life Measures in Cancer Patients at the Mayo Clinic in April 2002 and subsequently were published in Mayo Clinic Proceedings...
  25. ncbi The use of the sexual function questionnaire as a screening tool for women with sexual dysfunction
    Frances Quirk
    Schools of Psychology and Medicine, James Cook University, Townsville, Australia
    J Sex Med 2:469-77. 2005
    ..CONCLUSIONS: The SFQ is a valuable new tool for detecting the presence of FSD and identifying the specific components of sexual functions affected (desire, arousal, orgasm, or dyspareunia)...
  26. ncbi Assessing clinical significance in measuring oncology patient quality of life: introduction to the symposium, content overview, and definition of terms
    Jeff A Sloan
    Department of Health Sciences Research, Mayo Clinic, Rochester, Minn 55905, USA
    Mayo Clin Proc 77:367-70. 2002
    ..A secondary goal is to stimulate further discussion and research in the interpretation of QOL assessments...